Postnatal development of δ-opioid receptor subtypes in mice

British Journal of Pharmacology

Volumn 120, Issue 6, 1997, Pages 989-994

  Negri, L ^a   Severini, C ^a   Lattanzi, R ^a   Potenza, R L ^a   Melchiorri, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

receptor subtypes; Deltorphins; Mouse brain homogenates; Mouse vas deferens; Postnatal development

Indexed keywords

DELTA OPIATE RECEPTOR; DELTORPHIN; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; LIGAND; NALTRINDOLE;

ANIMAL TISSUE; ARTICLE; BINDING SITE; BRAIN; BRAIN HOMOGENATE; DRUG POTENCY; ELECTROSTIMULATION; FEMALE; MALE; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; VAS DEFERENS;

ANIMALS; ANIMALS, SUCKLING; BRAIN; ELECTRIC STIMULATION; ENKEPHALIN, D-PENICILLAMINE (2,5)-; ENKEPHALINS; FEMALE; MALE; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; RECEPTORS, OPIOID, DELTA; VAS DEFERENS;

EID: 0030935739     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0700990     Document Type: Article

References (39)

1. BILSKY, E.J., BERNSTEIN, R.N., PASTERNAK, G.W., HRUBY, V.J., PATEL, D., PORRECA, F. & LAI, J. (1994). Selective inhibition of [D-Ala2, Glu4]-deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxinucleotide to an opioid delta receptor. Life Sci., 55, PL 37-43.
2. BUZAS, B., IZENWASSER, S., PORTOGHESE, P.S & COX, B.M. (1994). Evidence for delta-opioid subtypes regulating adenylyl cyclase activity in rat brain. Life Sci. Pharmacol. Lett., 54, PL 101-106.
3. CHA, X.Y., XU, H., RICE, K.C., PORRECA, F., LAI, J., ANANTHAN, S. & ROTHMAN, R.B. (1995). Opioid peptide receptor studies. 1. Identification of a novel δ-opioid receptor binding site in rat brain membranes. Peptides, 16, 191-198.
4. EVANS, C.J., KEITH, D.E., MORRISON, H., MAGENDZO, K. & EDWARDS, R.H. (1992). Cloning of a delta opioid receptor by functional expression. Science, 258, 1952-1955.
5. ERSPAMER, V., MELCHIORRI, P., FALCONIERI ERSPAMER, G., NEGRI, L., CORSI, R., SEVERINI, C., BARRA, D., SIMMACO, M. & KREIL, G. (1989). Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ-opioid binding sites. Proc. Natl. Acad. Sci. U.S.A., 86, 5188-5192.
6. FANG, L., KNAPP, R.J., HORVATH, R., MATSUNAGA, T.O., HAASETH, R.C., RUBY, V.J., PORRECA, F. & YAMAMURA, H.I. (1994). Characterization of [3H]Naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity. J. Pharmacol. Exp. Ther., 268, 836-846.
7. FONG, T.M., YU, H. & STRADER, C.D. (1992). Molecular basis of the species selectivity of the neurokinin-1 receptor antagonists CP-96, 345 and RP67580. J. Biol. Chem., 267, 25668-25671.
8. FUKUDA, K., KATO, S., MORI, K., NISHI, M. & TAKESHIMA, H. (1993). Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. FEBS Lett., 327, 311-314.
9. JIANG, Q., TAKEMORI, A.E., SULTANA, M., PORTOGHESE, P.S., BOWEN, W.D., MOSBERG, H.I. & PORRECA, F. (1991). Differential antagonism of delta antinociception by [D-Ala2,Leu5,Cy-s6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther., 257, 1069-1075.
10. KIEFFER, B.L., BEFORT, K., GAVERIAUX-RUFF, C. & HIRTH, C.J. (1992). Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U.S.A., 89, 12048-12052.
11. KITCHEN, I., CHANA, U., LESLIE, F.M., MELCHIORRI, P., NEGRI, L. & HILL, R.G. (1996). Differential competition of δ-opioid receptors in weaned and non-weaned 25-day old rats assessed by receptor autoradiography. In 27th meeting of the International Narcotics Research Conference, abstract book, ed. Cox, B. M67, 73. Los Angeles: N.I.D.A.
12. KITCHEN, I., CROOK, T.J., MUHAMMAD, B.Y. & HILL, R.G. (1994). Evidence that weaning stimulates the developmental expression of a δ-opioid receptor subtype in the rat. Dev. Brain Res., 78, 147-150.
13. KITCHEN, I., LESLIE, F.M., KELLY, M., BARNES, R., CROOK, T.J., HILL, R.G., BORSODI, A., TOTH, G., MELCHIORRI, P. & NEGRI, L. (1995). Development of delta-opioid receptor suptypes and the regulatory role of weaning: radioligand binding, autoradiography and in situ hybridisation studies. J. Pharmacol. Exp. Ther., 275, 1597-1607.
14. 5]enkephalin: a highly selective high affinity radioligand for delta opioid receptors with exceptional specific activity. J. Pharmacol. Exp. Ther., 258, 1077-1083.
15. KONG, H., RAINOR, K., YASUDA, K., MOE, S.T., PORTOGHESE, P.S., BELL, G.I. & REISINE, T. (1993). A single residue, aspartic acid 95, in the δ-opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem., 268, 23055-23058.
16. LAI, J., BILSKY, E.J. & PORRECA, F. (1995). Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands. J. Rec. Sign. Transd. Res., 15, 643-650.
17. LAI, J., BILSKY, E.J., ROTHMAN, R.B. & PORRECA, F. (1994). Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta2-agonist antinociception. Neuro Report, 5, 1049-1052.
18. LOWRY, O.H., ROSEBROUGH, N.J., FARR, L. & RANDALL, R.J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
19. MATTIA, A., FARMER, S.C., TAKEMORI, A.E., SULTANA, M., PORTOGHESE, P.S., MOSBERG, H.I., BOWEN, W.D. & PORRECA, F. (1992). Spinal opioid delta antinociception in the mouse: mediation by a 5′-NTII-sensitive delta receptor subtype. J. Pharmacol. Exp. Ther. 260, 518-525.
20. MATTIA, A., VANDERAH, T., MOSBERG, H.I. & PORRECA, F. (1991). Lack of antinociceptive cross tolerance between [D-Pen2,D-Pen5]enkephalin and [Ala2]deltorphin II in mice: Evidence for delta receptor subtypes. J. Pharmacol. Exp. Ther., 258, 583-581.
21. MCDOWELL, J. & KITCHEN, I. (1986). Ontogenesis of delta-opioid receptors in rat brain using [3H][D-Pen2,D-Pen5]enkephalin as a binding ligand. Eur. J. Pharmacol., 128, 287-289.
22. MELCHIORRI, P., NEGRI, L., FALCONIERI ERSPAMER, G., SEVERINI, C., CORSI, R., SOAJE, M., ERSPAMER, V. & BARRA, D. (1991). Structure-activity relationships of the δ-opioid selective agonists, deltorphins. Eur. J. Pharmacol., 195, 201-207.
23. NEGRI, L., CORSI, R., POTENZA, R.L. (1993). Differential postnatal development of δ-opioid receptors in mice. Pharmacol. Res., 27, 45-46.
24. NEGRI, L., POTENZA, R.L., CORSI, R. & MELCHIORRI, P. (1991). Evidence for two subtypes of delta-opioid sites in rat brain. NeuroReport, 4, 1143-1146.
25. 1B receptors. Nature, 360, 161-163.
26. PORTOGHESE, P.S., SULTANA, M., NAGASE, H. & TAKEMORI, A.E. (1992). A highly selective δ-opioid receptor antagonist: 7-benzylidene-naltrexone. Eur. J. Pharmacol., 218, 195-196.
27. RENDA, T., NEGRI, L., TOOYAMA, I., CASU, C. & MELCHIORRI, P. (1993). Autoradiographic study on [3H][D-Ala2]deltorphin-I binding sites in rat brain. NeuroReport, 4, 1143-1146.
28. RICHARDSON, A., DEMOLIOU-MANSON, C. & BARNARD, E.A. (1992). Guanine nucleotide-binding protein-coupled and -uncoupled states of opioid receptors and their relevance to the determination of subtypes. Proc. Natl. Acad. Sci. U.S.A., 89, 10198-10202.
29. ROTHMAN, R.B., BOWEN, W.D. & BYKOV, V. (1984). Preparation of rat brain membranes greatly enriched with type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents. Neuropeptides, 4, 201-215.
30. SIMONIN, F., BEFORT, K., GAVERIAUX-RUFF, C., MATTHES, H., NAPPEY, V., LANNES, B., MICHELETTI, G. & KIEFFER, B. (1994). The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain. Mol. Pharmacol., 46, 1015-1021.
31. SOFUOGLU, M., PORTOGHESE, P.S. & TAKEMORI, A.E. (1991). Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: Evidence for delta opioid receptor subtypes: J. Pharmacol. Exp. Ther., 257, 676-680.
32. SOFUOGLU, M., PORTOGHESE, P.S. & TAKEMORI, A.E. (1992). Delta opioid receptor binding in mouse brain: evidence for heterogeneous binding sites. Eur. J. Pharmacol., 216, 273-277.
33. SPAIN, J.W., ROTH, B.I. & COSCIA, C.J. (1985). Differential ontogeny of multiple opioid receptors (μ, δ and κ). J. Neurosci., 5, 584-588.
34. STANDIFER, K.M., CLARK, J.A. & PASTERNAK, G.W. (1993). Modulation of mul-opioid binding by magnesium; evidence for multiple receptor conformations. J. Pharmacol. Exp. Ther., 266, 106-113.
35. VAUGHN, L.K., WIRE, W.S., DAVIS, P., SHIMOHIGASHI, Y., TOTH, G., KNAPP, R.J., RUBY, V.J., BURKS, T.F. & YAMAMURA, H.I. (1990). Differentiation between rat brain and mouse vas deferens δ opioid receptor. Eur. J. Pharmacol., 177, 99-101.
36. WHITTINGHAM, D.G. & WOOD, M.J. (1983). The Mouse in Biomedical Research, ed. Foster, H.L. Small, J.D. & Fox, J.G. p. 146. New York: Academic Press.
37. WILD, K.D., CARLISI, V.J., MOSBERG, H.I., BOWEN, W.D., PORTOGHESE, P.S., SULTANA, M. & TAKEMORI, A.E. (1993). Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens. J. Pharmacol. Exp. Ther., 264, 831-837.
38. nex binding sites in mouse brain: further evidence for δ receptor heterogeneity. Peptides, 14, 893-907.
39. YASUDA, K., RAYNOR, K., KONG, H., BREDER, C.D., TAKEDA, J., REISINE, T. & BELL, G.I. (1993). Cloning and functional comparison of κ and δ opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U.S.A., 90, 6736-6740.